Norman Lippmann
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 10
Norman Lippmann
34 papers receiving 508 citations
Peers
Comparison fields: 5 of 92
- Applied Microbiology and Biotechnology 77
- Molecular Medicine 177
- Endocrinology 66
- Pollution 105
- Clinical Biochemistry 43
Countries citing papers authored by Norman Lippmann
This map shows the geographic impact of Norman Lippmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Lippmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Lippmann more than expected).
Fields of papers citing papers by Norman Lippmann
This network shows the impact of papers produced by Norman Lippmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Lippmann. The network helps show where Norman Lippmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Norman Lippmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 5 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 0 | |
| 13 | 2020 | 18 | |
| 14 | 2019 | 3 | |
| 15 | 2017 | 42 | |
| 16 | 2017 | 4 | |
| 17 | 2017 | 21 | |
| 18 | 2016 | 41 | |
| 19 | 2015 | 5 | |
| 20 | 2014 | 67 |
About Norman Lippmann
Norman Lippmann is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry, Endocrinology and Critical Care and Intensive Care Medicine, having authored 37 papers that have together received 525 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Bacterial Identification and Susceptibility Testing (6 papers), Surgical site infection prevention (5 papers), Nanoplatforms for cancer theranostics (4 papers), Pneumonia and Respiratory Infections (4 papers), Photodynamic Therapy Research Studies (4 papers), Clostridium difficile and Clostridium perfringens research (4 papers) and Orthopedic Infections and Treatments (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (77 citations), Molecular Medicine (177 citations), Endocrinology (66 citations), Pollution (105 citations) and Clinical Biochemistry (43 citations). Norman Lippmann has collaborated with scholars based in Germany, Ethiopia and Australia. Frequent co-authors include Christoph Lübbert, Arne C. Rodloff, Fritz Sörgel, Martina Kinzig, Thilo Busch, Tim Eckmanns, Udo X. Kaisers, Tanja Ducomble, Brigitte König and Sebastian Wendt. Their work appears in journals such as American Journal of Infection Control, PLoS ONE, Scientific Reports, Surgical Infections and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.